Hydrolyzed collagen undergoes targeted enzymatic cleavage into low-molecular-weight fragments between 2,000 and 5,000 Daltons, preventing degradation in the gastric lumen into free amino acids. Specific oligopeptides, primarily prolyl-hydroxyproline (Pro-Hyp) and hydroxyprolyl-glycine (Hyp-Gly), are selectively absorbed intact across intestinal enterocytes through proton-coupled peptide transporter 1 (PEPT1) [3], [4]. These circulating dipeptides reach peak plasma concentrations within 60 to 120 minutes post-ingestion. Unlike non-hydrolyzed gelatin, these targeted peptide sequences exhibit targeted tropism for dermal fibroblasts, synovial cells, and tenocytes, activating cell surface integrins and promoting transcription of endogenous procollagen type I [4].
Systematic reviews of randomized, double-blind trials confirm substantial clinical improvements in structural skin parameters [1], [2]. In multiple sham-controlled evaluations, daily intake of 2.5 g to 10 g over 90 days resulted in significant increases in stratum corneum hydration and viscoelastic recovery, alongside marked reductions in transepidermal water loss (TEWL) [2], [7]. Patients managing chronic inflammatory dermatoses, including neurodermatitis or impaired cutaneous integrity from intertrigo, show preserved epidermal barrier resistance when oral supplementation reinforces local dermal architecture [3]. Concomitant oral supplementation with co-factors like magnesium glycinate further supports enzymatic collagen stabilization [8].
Beyond cosmetic dermatology, the co-administration of 10 g to 15 g of type I and III hydrolyzed collagen peptides alongside 50 mg of ascorbic acid substantially augments muscle-tendon kinetic performance [5]. Ascorbic acid acts as an obligatory electron donor for prolyl 4-hydroxylase, maintaining cross-linking integrity during de novo fibril assembly. Magnetic resonance imaging and biopsy data confirm elevated levels of circulating amino-terminal propeptide of type I collagen (PINP), accelerating extracellular matrix accretion in athletes rehabilitating chronic patellar tendinopathies and high-impact structural microtrauma [5], [8].